Simplex Trading’s Purple Biotech PPBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-597
Closed -$2.01K 10098
2026
Q1
$2.41K Sell
597
-326
-35% -$1.76K ﹤0.01% 8302
2025
Q4
$6.07K Buy
923
+907
+5,669% +$6.58K ﹤0.01% 7318
2025
Q3
$0 Buy
16
+11
+220% +$197 ﹤0.01% 9827
2025
Q2
$0 Buy
+5
New +$124 ﹤0.01% 9513
2024
Q3
Sell
-4
Closed -$302 9328
2024
Q2
$0 Buy
+4
New +$464 ﹤0.01% 9588
2024
Q1
Sell
-19
Closed -$3K 9647
2023
Q4
$3K Sell
19
-20
-51% -$4.43K ﹤0.01% 8129
2023
Q3
$8K Sell
39
-7
-15% -$1.67K ﹤0.01% 7350
2023
Q2
$12K Sell
46
-53
-54% -$19K ﹤0.01% 7254
2023
Q1
$34K Buy
+99
New +$37.1K ﹤0.01% 6373
2022
Q4
Sell
-30
Closed -$11.5K 10148
2022
Q3
$12K Buy
30
+18
+150% +$8.41K ﹤0.01% 8085
2022
Q2
$5K Buy
+12
New +$7.19K ﹤0.01% 8853
2021
Q2
Sell
-29
Closed -$26.6K 10563
2021
Q1
$23K Buy
29
+28
+2,800% +$26.1K ﹤0.01% 7350
2020
Q4
$0 Buy
+1
New +$843 ﹤0.01% 8905

Other funds holding PPBT

Simplex Trading's PPBT Position: Q2 2026 in Review

Simplex Trading sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 597 shares — an estimated $2.01K sold.

Simplex Trading first reported a position in PPBT in Q4 2020 and held it in 13 quarters. The position peaked at $34K in Q1 2023. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Simplex Trading reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 597 Purple Biotech shares in Q2 2026, an estimated $2.01K.
  • Simplex Trading first reported a position in Purple Biotech in Q4 2020 and held it in 13 quarters.
  • Simplex Trading's Purple Biotech position peaked at $34K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.